IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment
Name
nihms885203.pdf
Size
1.25 MB
Format
Adobe PDF
Checksum (MD5)
7115f35fc5abb0b42d7595c0e0481a23
Author(s)
Nirschl, Christopher J.
Suárez-Fariñas, Mayte
Izar, Benjamin
Dannenfelser, Ruth
Tirosh, Itay
Liu, Yong
Zhu, Qian
Devi, K. Sanjana P.
Chau, David
Rezaee, Melika
Date Issued
June 2017
Journal
Cell
Publisher
Elsevier
Citation
Nirschl, Christopher J. et al. “IFNγ-Dependent Tissue-Immune Homeostasis Is Co-Opted in the Tumor Microenvironment.” Cell 170, 1 (June 2017): 127–141 © 2017 Elsevier Inc
Version
Author's final manuscript
Abstract
Homeostatic programs balance immune protection and self-tolerance. Such mechanisms likely impact autoimmunity and tumor formation, respectively. How homeostasis is maintained and impacts tumor surveillance is unknown. Here, we find that different immune mononuclear phagocytes share a conserved steady-state program during differentiation and entry into healthy tissue. IFNγ is necessary and sufficient to induce this program, revealing a key instructive role. Remarkably, homeostatic and IFNγ-dependent programs enrich across primary human tumors, including melanoma, and stratify survival. Single-cell RNA sequencing (RNA-seq) reveals enrichment of homeostatic modules in monocytes and DCs from human metastatic melanoma. Suppressor-of-cytokine-2 (SOCS2) protein, a conserved program transcript, is expressed by mononuclear phagocytes infiltrating primary melanoma and is induced by IFNγ. SOCS2 limits adaptive anti-tumoral immunity and DC-based priming of T cells in vivo, indicating a critical regulatory role. These findings link immune homeostasis to key determinants of anti-tumoral immunity and escape, revealing co-opting of tissue-specific immune development in the tumor microenvironment. Keywords: dendritic cells; homeostasis; differentiation; IFNγ; tumor microenvironment; melanoma tolerance; immunotherapy; suppressor-of-cytokine-signaling 2 (SOCS2); tissue mononuclear phagocytes
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Massachusetts Institute of Technology. Department of Biology
Massachusetts Institute of Technology. Department of Chemistry
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/J.CELL.2017.06.016
